Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Exp Neurol. 2017 Mar 21;292:179–192. doi: 10.1016/j.expneurol.2017.03.010

Figure 6.

Figure 6

α2-adrenoceptor binding in mPFC of rats exposed to acute or chronic treatment with WIN 55,212-2. There was no change in the α2-adrenoceptor mRNA expression in the mPFC following acute or repeated administration of WIN 55,212-2 compared to control. However, following a period of abstinence from chronic WIN 55,212-2 exposure, there was a significant increase in α2-adrenoceptor mRNA binding in the mPFC. *P 0.05 vs WIN 55,212-2. Bottom panels show boxed region at a higher magnification.